Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Oruka Therapeutics (HQ1.XETRA) Q2 2026 Earnings
HQ1.XETRA
13
May
Confirmed
Q2 2026
-0.47
-0.45
-0.43
-0.41
Details
Expected EPS
-0.4667381144
Actual EPS
-0.409632
Surprise EPS
0.06
Surprise Percent
+12.24%
Description
Oruka Therapeutics (HQ1.XETRA) has reported earnings of -0.409632 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login